NVISION Imaging Technologies is a pioneering German MedTech company revolutionizing medical imaging with its quantum-based metabolic MRI platform. Founded in 2021 as a spin-off from the University of Ulm and Max Planck Institute, NVISION aims to enable paradigm-shifting insights into human metabolism. Their technology utilizes hyperpolarized agents to significantly boost MRI signal strength, allowing for non-invasive, real-time visualization of metabolic processes at the cellular level. This breakthrough approach holds immense potential for early diagnosis, monitoring, and personalized treatment of diseases like cancer, neurodegenerative conditions (e.g., Alzheimer's), and metabolic disorders (e.g., diabetes, NASH). By observing metabolic changes before anatomical ones, NVISION seeks to transform patient outcomes and advance precision medicine.
Serves as the primary hub for research and development, corporate leadership, and strategic operations for their quantum-enhanced MRI technology.
Advanced research laboratories equipped for quantum physics, hyperpolarization technology development, and pre-clinical imaging studies. Located within a science and technology park fostering innovation.
A dynamic, research-intensive, and collaborative environment blending academic rigor with startup agility. Focuses on innovation, scientific excellence, and translating cutting-edge research into impactful medical solutions. Employees are typically highly skilled scientists, engineers, and medical technology professionals.
The Ulm headquarters is central to NVISION's identity, leveraging its origins from the University of Ulm. It's the birthplace of their core technology and the center for ongoing innovation and product development.
While NVISION Imaging Technologies is headquartered in Ulm, Germany, its focus and intended impact are global. They support advancements in medical imaging worldwide through their pioneering research, planned clinical collaborations, and the development of technology aimed at addressing global health challenges. Their solutions are designed for eventual distribution and use in healthcare systems internationally.
Lise-Meitner-Str. 13
Ulm
Baden-Württemberg
Germany
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NVision Imaging Technologies' leadership includes:
NVision Imaging Technologies has been backed by several prominent investors over the years, including:
As a company founded in 2021, NVISION Imaging Technologies is primarily led by its founding executive team. No major public announcements regarding C-suite level hires or departures have been noted in the last 12 months, indicating stability in its core leadership as it scales its operations and technology development. Key scientific advisory board appointments may occur but are distinct from daily executive roles.
Discover the tools NVision Imaging Technologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NVISION Imaging Technologies likely uses standard professional email formats. Common formats for companies of this nature include [first_initial][lastname] or [firstname].[lastname] followed by the company domain.
[first_initial][lastname]@nvision-imaging.com
Format
sbrosh@nvision-imaging.com
Example
90%
Success rate
nvision-imaging.com (Official Website) • January 25, 2023
NVISION Imaging Technologies GmbH announced the successful closing of its €30 million (US$32.7 million) Series A financing round. The round was led by bfv Partners (BioMedPartners) and included new investors Andera Partners, Vulcan Capital, ZAZ Ventures, and Future Industry Ventures, alongside existing seed investors. The funds will be used to advance NVISION's pioneering quantum-based metabolic MRI platform, develop its hyperpolarization technology, and prepare for clinical trials....more
AuntMinnieEurope.com • November 14, 2022
NVISION Imaging Technologies presented its advancements in quantum-enhanced metabolic MRI at the Radiological Society of North America (RSNA) 2022 annual meeting. The company highlighted its technology's potential to provide unprecedented insights into cellular metabolism for early disease detection and personalized medicine....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NVision Imaging Technologies, are just a search away.